Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213PUGH, M. T; O'BOYLE, K. M; MOLLOY, A. G et al.Psychopharmacologia. 1985, Vol 87, Num 3, pp 308-312, issn 0033-3158Article

Dopamine receptors in brain and periphery: some prospectsCAMSONNE, R.Neurochemistry international. 1987, Vol 10, Num 1, pp 35-37, issn 0197-0186Article

Dopamine receptors in the brain and periphery: State of the artSTRANGE, P. G.Neurochemistry international. 1987, Vol 10, Num 1, pp 27-33, issn 0197-0186Article

Evidence for the presence of D₁ and ₂ dopamine receptors in the rat adrenal cortexMISSALE, C; MEMO, M; LIBERINI, P et al.European journal of pharmacology. 1985, Vol 109, Num 2, pp 315-316, issn 0014-2999Article

EVIDENCE FOR THE PRESENCE OF D₂ AND 5-HT₂ RECEPTORS IN THE HUMAN PREFONTAL CORTEXMITA T; KUNO T; NAKAI H et al.1982; JAPANESE JOURNAL OF PHARMACOLOGY; ISSN 0021-5198; JPN; DA. 1982; VOL. 32; NO 6; PP. 1027-1032; BIBL. 24 REF.Article

¹²⁵I-spiperone: a novel ligand for D₂ dopamine receptorsGUNDLACH, A. L; LARGENT, B. L; SNYDER, S. H et al.Life sciences (1973). 1984, Vol 35, Num 19, pp 1981-1988, issn 0024-3205Article

New insight into structural and stereochemical requirements for selective, high affinity ligands at the dopamine D₂ receptorIMHOF, R; GODEL, T; BURKARD, W. P et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 75S-80S, issn 0197-0186, SUPConference Paper

TL333, a benzhydro[G]quinoline, stimulates both D-1 and D-2 dopamine receptors: implications for the selectivity of LY 141865 towards the D-2 receptorITOH, Y; GOLDMAN, M. E; KEBABIAN, J. W et al.European journal of pharmacology. 1985, Vol 108, Num 1, pp 99-101, issn 0014-2999Article

Further characterization of structural requirements for agonists at the striatal dopamine D₂ receptor and a comparison with those at the striatal dopamine D₁ receptor: studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatumSEILER, M. P; MARKSTEIN, R.Molecular pharmacology. 1984, Vol 26, Num 3, pp 452-457, issn 0026-895XArticle

EFFECTS OF PUTATIVE DOPAMINE AUTORECEPTOR AGONISTS IN PHARMACOLOGICAL MODELS RELATED TO DOPAMINERGIC AND NEUROLEPTIC ACTIVITYARNT J; CHRISTENSEN AV; HYTTEL J et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 86; NO 2; PP. 185-198; BIBL. 2 P.Article

Solubilization of dopamine-D₂receptors from synaptosomal membranes of the bovine caudate nucleusKIDRIC, M; PETROVIC, J; SOSKIC, V et al.British journal of pharmacology. 1984, Vol 83, Num 3, pp 687-695, issn 0007-1188Article

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonistWADDINGTON, J. L; ÓBOYLE, K. M.Pharmacology & therapeutics (Oxford). 1989, Vol 43, Num 1, pp 1-52, issn 0163-7258Article

Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactionsBARONE, P; DAVIS, T. A; BRAUN, A. R et al.European journal of pharmacology. 1986, Vol 123, Num 1, pp 109-114, issn 0014-2999Article

Dopamine receptors in brain and peripherySEEMAN, P; GRIGORIADIS, D; STRANGE, P. G et al.Neurochemistry international. 1987, Vol 10, Num 1, pp 1-25, issn 0197-0186Article

The effect of dopamine D2, D5 receptor and transporter (SLC6A3) polymorphisms on the cue-elicited heroin craving in ChineseYIFENG LI; CHUNHONG SHAO; DANDAN ZHANG et al.American journal of medical genetics. Part B, Neuropsychiatric genetics. 2006, Vol 141, Num 3, pp 269-273, issn 1552-4841, 5 p.Article

Identification and characterization of two nuclear factor-κB sites in the regulatory region of the dopamine D2 receptorBONTEMPI, Sandra; FIORENTINI, Chiara; BUSI, Chiara et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 5, pp 2563-2570, issn 0013-7227, 8 p.Article

AMPHETAMINE-INDUCED HYPOLOCOMOTION IN MICE WITH MORE BRAIN D₂ DOPAMINE RECEPTORSHELMESTE DM; SEEMAN P.1982; PSYCHIATRY RESEARCH; ISSN 0165-1781; NLD; DA. 1982; VOL. 7; NO 3; PP. 351-359; BIBL. 2 P.Article

INTERACTIONS OF ERGOT ALKALOIDS WITH ANTERIOR PITUITARY D-2 DOPAMINE RECEPTORSSIBLEY DR; CREESE I.1983; MOLECULAR PHARMACOLOGY; ISSN 0026-895X; USA; DA. 1983; VOL. 23; NO 3; PP. 585-593; BIBL. 50 REF.Article

YM-09151-2: A POTENT ANTAGONIST FOR A PERIPHERAL D₂-DOPAMINE RECEPTORGREWE CW; FREY EA; COTE TE et al.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 81; NO 1; PP. 149-152; BIBL. 10 REF.Article

Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA₁ and DA₂ receptor agonists and antagonistsSABOUNI, M. H; ALKADHI, K. A; LOKHANDWALA, M. F et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 1, pp 65-70, issn 0022-3565Article

Evidence that the enhancement of dopamine function by repeated electroconvulsive shock requires concomitant activation of D₁-like and D₂-like dopamine receptorsSMITH, S. E; SHARP, T.Psychopharmacologia. 1997, Vol 133, Num 1, pp 77-84, issn 0033-3158Article

The dopamine D-2 antagonist, Ro22-1319, inhibits the persistent behavioral syndrome induced by iminodipropionitrile (IDPN) in miceCADET, J. L; BRAUN, T; FREED, W. J et al.Experimental neurology (Print). 1987, Vol 96, Num 3, pp 594-600, issn 0014-4886Article

Dopamine D₂ receptor subtypes couple to different second messenger systemsTODD, R. D; MACK, K. J; GANDELMAN, K.-Y et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 23S-26S, issn 0197-0186, SUPConference Paper

Influence of the dopamine D₂ receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawalLUCHT, Michael J; KUEHN, Kail U; FREYBERGER, Harald J et al.Pharmacogenetics (London). 2001, Vol 11, Num 8, pp 647-653, issn 0960-314XArticle

[³H] 205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D₂ receptorsCLOSSE, A; FRICK, W; MARKSTEIN, R et al.Journal of neural transmission. 1985, Vol 62, Num 3-4, pp 231-248, issn 0300-9564Article